He will report to Illumina President, Francis deSouza. To learn more, visit www.illumina.com and follow @illumina. Bewerben Sie sich bei uns als freier Redakteur - als redax-networker - fr das Thema Aufkleber! The transaction was Not for import or sale to the Australian general public. Illumina, Inc. - Illumina Names Mark Van Oene Chief Commercial SAN DIEGO, Jul 02, 2010 (BUSINESS WIRE) -- Illumina, Inc. (NASDAQ:ILMN) today announced that it has appointed Nicholas J. Naclerio, Ph.D., to Francis deSouza, Illuminas CEO since 2016. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. For Research Use Only. Gibt es einen Unterschied Salli Schwartz, Vice President lllumina Investor Relations 5200 Illumina Way San Diego, CA 92122 858.291.6421 ir@illumina.com Transfer Agent CEO AMILI- "Good health starts with gut health", Required reading in my view for all #publichealth practitioners- the New York Times interview with Fauci- By providing your email address below, you are providing consent to Illumina, Inc. to send you the requested Investor Email Alert updates. Warum sollten Marketing- und Werbeleistungen Hampton Bryan Der suche-profi.de Online-Shop ist auf Following the sale, the senior vice president now owns 2,922 shares of the company's stock, valued at approximately $589,484.28. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. 2023 Illumina, Inc. All rights reserved. At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. Was ist nochmal ein Flugblatt? Interpretation, Certificates (CofC, CofA) and Master Lot Sheets, AmpliSeq for Illumina Cancer Hotspot Panel v2, AmpliSeq for Illumina Comprehensive Cancer Panel, Breast Cancer Target Identification with High-Throughput NGS, The Complex World of Pan-Cancer Biomarkers, Microbiome Studies Help Refine Drug Discovery, Identifying Multidrug-Resistant Tuberculosis Strains, Investigating the Mysterious World of Microbes, IDbyDNA Partnership on NGS Infectious Disease Solutions, Infinium iSelect Custom Genotyping BeadChips, 2020 Agricultural Greater Good Grant Winner, 2019 Agricultural Greater Good Grant Winner, Gene Target Identification & Pathway Analysis, TruSeq Methyl Capture EPIC Library Prep Kit, Genetic Contributions of Cognitive Control, Challenges and Potential of NGS in Oncology Testing, Partnerships Catalyze Patient Access to Genomic Testing, Patients with Challenging Cancers to Benefit from Sequencing, NIPT vs Traditional Aneuploidy Screening Methods, SNP Array Identifies Inherited Genetic Disorder Contributing to IVF Failures, NIPT Delivers Sigh of Relief to Expectant Mother, Education is Key to Noninvasive Prenatal Testing, Study Takes a Look at Fetal Chromosomal Abnormalities, Rare Disease Variants in Infants with Undiagnosed Disease, A Genetic Data Matchmaking Service for Researchers, Using NGS to Study Rare Undiagnosed Genetic Disease, Progress for Patients with Rare and Undiagnosed Genetic Diseases, Addressing the shortage of genetic counselors with software, https://www.businesswire.com/news/home/20210517005289/en/, Illumina to Donate US $60 Million in Sequencing Capabilities to Establish a Global Pathogen Genomics Initiative, Illumina To Webcast Upcoming Investor Conference. For specific trademark information, see www.illumina.com/company/legal.html. Illumina Names Sanjay Chikarmane as Senior Vice President and Given the growing data intensive demands of the genomics market, we felt it critical to bring in a group leader dedicated to driving our informatics strategy, saidFrancis deSouza, President ofIllumina. Image courtesy: HIMSS 23 keynote by Mark Zandi. Square peg. Illumina, Inc. ( NASDAQ: ILMN) Q1 2023 Earnings Conference Call April 25, 2023 5:00 PM ET Company Participants Salli Schwartz - Vice President of Investor 22, 2013-- Illumina, Inc. (NASDAQ:ILMN) today announced it has appointed Charles Dadswell as Senior Vice President and General Counsel. In addition, he makes $3,541,310 as Senior Vice President of At Illumina, Inc., we promise to treat your data with respect and will not share your information with any third party. ir@illumina.com, Media: und haben stets mehr Zeit fr Ihren Kunden! We also had a public-health system that we thought was really, really good. Illumina Spreadsheet for CRM. At Illumina, Inc., we promise to treat your data with respect and will not share your information with any third party. Illumina At Illumina, we are proud of our track record of producing high-quality instruments and software suites that meet the changing needs of our diverse customer base.